China And U.S. To Collaborate In TCM Research
This article was originally published in PharmAsia News
As part of the Fourth Sino-US Strategic Economic Dialog, China and the U.S. held a forum on traditional Chinese medicine at the National Institutes of Health. China's Ministry of Health and the U.S. Health and Human Services signed a memorandum of understanding on collaboration in integrated medicine and TCM. According to the agreement, both parties will set up a collaborative team on TCM to encourage their health care organizations and scientists to cooperate in basic science and clinical research of acupuncture, as well as the safety and effectiveness of TCM. Furthermore, the two sides have reached a consensus on collaboration in drugs, medical devices and food safety. (Click here for more - Chinese Language)
You may also be interested in...
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.